Clinical Trials Directory

We are doing this study to compare the usual treatment of Nivolumab and ipilimumab to using the usual treatment plus surgery for people with sarcomatoid mesothelioma. We want to find out if adding surgery to the immunotherapy regimen is effective in stabilizing this type of cancer.

We are doing this study to find the best dose of the study drug, ABBV-400, and to see if it is a safe and effective option for treating cancer.

We are doing this study to find out if an experimental drug called ABBV-400 (the study drug) is a safe and effective option for treating various types of solid tumors.

We are doing this study to find out if an experimental drug called ABBV-453 (the study drug) is a safe and effective treatment for multiple myeloma. We want to identify the most appropriate dose and schedule to give patients the study drug.

We are doing this study to find out if an experimental study drug called venetoclax (Venclexta) is a safe and effective treatment for relapsed or refractory multiple myeloma. We want to see if people have better outcomes when they're treated with the study drug and standard drugs, carfilzomib (Kyprolis) and dexamethasone, versus just the standard drugs on their own.

We are doing this study to collect information about people with oligometastasis for future use.

We are doing this study to understand the benefit of using PET scan in addition to the standard of care CT scan to plan for radiation therapy.

The PET-CT scan may allow your radiation doctor to fine tune the radiation plan or the delivery of radiation to your cancer.

We are doing this study to find out if a new experimental drug called NVL-655 (the study drug) is a beneficial option for people with NSCLC.